Wilbanks Smith & Thomas Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-277	Closed	-$48K	–	1463
2018 Q3	$48K	Buy	+277	New	+$39.9K	﹤0.01%	695

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's GWPH Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 277 shares — an estimated $48K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in GWPH in Q3 2018 and held it in 1 quarter. The position peaked at $48K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

Wilbanks Smith & Thomas Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Wilbanks Smith & Thomas Asset Management sold 277 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $48K.
Wilbanks Smith & Thomas Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 1 quarter.
Wilbanks Smith & Thomas Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $48K in Q3 2018.
277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.